Actinium Pharmaceuticals, Inc. (ATNM) stock price, news, quote and history

Actinium Pharmaceuticals, Inc. (ATNM) Stock Price, News, Quote & History

Actinium Pharmaceuticals Announces Acceptance of ATNM-400 Abstract for Presentation at SABCS 2026 Highlighting Activity Across Therapy-Resistant Breast Cancer Models

Actinium Pharmaceuticals Announces Inducement Grant to New Employee

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Actinium Pharmaceuticals to Highlight First-in-Human Phase 1 Study of ATNM-400 a HER3-Targeted Non-PSMA Radiotherapy in Prostate Cancer at ESMO 2026

Actinium Pharma To Present First‑In‑Human Phase 1 Study Of ATNM‑400, HER3-Targeted, Non-PSMA Radiotherapy, In Metastatic Castration‑Resistant Prostate Cancer, At ESMO Congress 2026

Why Is Actinium Pharmaceuticals Stock Gaining Tuesday?

Actinium Pharmaceuticals Unveils ATNM‑400 Data at EANM 2026 with a First‑In‑Human HER3‑Targeted Radiotherapy Approach Beyond PSMA in Prostate Cancer

Actinium Pharmaceuticals Presents EANM 2026 Results Reinforcing ATNM-400's Pan-Tumor Potential Across Lung, Colorectal and Ovarian Cancer Models

Actinium Pharmaceuticals Presents New Preclinical Data From Its ATNM-400 Across Non-Small Cell Lung Cancer At 39th Annual Congress Of European Association Of Nuclear Medicine

Why Is Actinium Pharmaceuticals Stock Gaining Tuesday? - Actinium Pharmaceuticals (AMEX:ATNM)

Scans showed an experimental antibody stayed in prostate tumors through Day 7.

Actinium Pharmaceuticals, Inc. (ATNM) Presents at European Association of Nuclear Medicine Annual Congress 2026 - Slideshow

12 Health Care Stocks Moving In Monday's Intraday Session